These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17462692)

  • 81. [Microarrays for detection of HBV and HDV].
    Sun ZH; Zheng WL; Zhang B; Shi R; Ma WL
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):563-4. PubMed ID: 15387918
    [No Abstract]   [Full Text] [Related]  

  • 82. Distinctive properties of the hepatitis B virus envelope proteins.
    Molnar-Kimber KL; Jarocki-Witek V; Dheer SK; Vernon SK; Conley AJ; Davis AR; Hung PP
    J Virol; 1988 Feb; 62(2):407-16. PubMed ID: 3336067
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Novel transmembrane topology of the hepatitis B virus envelope proteins.
    Prange R; Streeck RE
    EMBO J; 1995 Jan; 14(2):247-56. PubMed ID: 7835336
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Characterization of early hepatitis B virus surface protein oligomers.
    Wounderlich G; Bruss V
    Arch Virol; 1996; 141(7):1191-205. PubMed ID: 8774681
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitor.
    Schieck A; Müller T; Schulze A; Haberkorn U; Urban S; Mier W
    Molecules; 2010 Jul; 15(7):4773-83. PubMed ID: 20657392
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Single-step purification of myristoylated and nonmyristoylated recoverin and substrate dependence of myristoylation level.
    Desmeules P; Penney SE; Salesse C
    Anal Biochem; 2006 Feb; 349(1):25-32. PubMed ID: 16376289
    [TBL] [Abstract][Full Text] [Related]  

  • 87. How does the biological function of N-myristoylation differ from that of N-palmitoylation?
    Rajala RV
    IUBMB Life; 2005 Aug; 57(8):597-8. PubMed ID: 16118118
    [No Abstract]   [Full Text] [Related]  

  • 88. Detection and characterization of small and large HDV antigens.
    Macnaughton TB; Lai MM
    Methods Mol Med; 2004; 95():99-105. PubMed ID: 14762299
    [No Abstract]   [Full Text] [Related]  

  • 89. Master of Disguise: Hepatitis Delta Virus Packaging and Spread Facilitated by Diverse Viral Envelope Proteins.
    Maya S; Ploss A
    Hepatology; 2020 Jan; 71(1):380-382. PubMed ID: 31465549
    [No Abstract]   [Full Text] [Related]  

  • 90. Hepatitis B and D viral receptors.
    Li J; Wands J
    Hepatology; 2016 Jan; 63(1):11-3. PubMed ID: 26315853
    [No Abstract]   [Full Text] [Related]  

  • 91. Long-Term Strategies for Poorly Water-Soluble Peptides: Combining Fatty Acid Modification with PAS Fusion.
    Zhu H; Hua H; Dong Y; Zhang J; Xu H; Ge X; Lu Q; Feng J
    Bioconjug Chem; 2023 Dec; 34(12):2366-2374. PubMed ID: 38037956
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diagnosis of HDV: From virology to non-invasive markers of fibrosis.
    Majeed NA; Hitawala AA; Heller T; Koh C
    Liver Int; 2023 Aug; 43 Suppl 1(Suppl 1):31-46. PubMed ID: 36621853
    [TBL] [Abstract][Full Text] [Related]  

  • 93. ATP5B Is an Essential Factor for Hepatitis B Virus Entry.
    Ueda K; Suwanmanee Y
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076968
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions.
    Kakkanas A; Karamichali E; Koufogeorgou EI; Kotsakis SD; Georgopoulou U; Foka P
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008946
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The N-Terminus Makes the Difference: Impact of Genotype-Specific Disparities in the N-Terminal Part of The Hepatitis B Virus Large Surface Protein on Morphogenesis of Viral and Subviral Particles.
    Jiang B; Wen X; Wu Q; Bender D; Carra G; Basic M; Kubesch A; Peiffer KH; Boller K; Hildt E
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823751
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hepatitis D infection: from initial discovery to current investigational therapies.
    Da BL; Heller T; Koh C
    Gastroenterol Rep (Oxf); 2019 Aug; 7(4):231-245. PubMed ID: 32477569
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhibition of N-myristoyltransferase1 affects dengue virus replication.
    Suwanmanee S; Mahakhunkijcharoen Y; Ampawong S; Leaungwutiwong P; Missé D; Luplertlop N
    Microbiologyopen; 2019 Sep; 8(9):e00831. PubMed ID: 30848105
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.
    Aldabe R; Suárez-Amarán L; Usai C; González-Aseguinolaza G
    Pathogens; 2015 Feb; 4(1):46-65. PubMed ID: 25686091
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Posttranslational modifications and secretion efficiency of immunogenic hepatitis B virus L protein deletion variants.
    Niedre-Otomere B; Bogdanova A; Bruvere R; Ose V; Gerlich WH; Pumpens P; Glebe D; Kozlovska T
    Virol J; 2013 Feb; 10():63. PubMed ID: 23442390
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent.
    Le Duff Y; Blanchet M; Sureau C
    J Virol; 2009 Dec; 83(23):12443-51. PubMed ID: 19759159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.